glp-1 receptor agonists benefits Frontiers Current Insights, Advantages and Challenges
Description
[8] [9] This medication is often prescribed for adults and children age 10 and older with type 2 diabetes (citation)
Autoimmune diseases encompass a diverse group of conditions characterized by inappropriate immune system activation against self-antigens
The new coverage could unlock millions of potential patients for Novo and Lilly, intensifying their competition in the obesity market
Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE
